Loading
Showed how radiation, including proton therapy, can be used in liver and pancreatic cancers previously considered unsuitable.
Theodore S. Hong is Director of Gastrointestinal Radiation Oncology at Massachusetts General Hospital Cancer Center. He is a radiation oncologist known for showing how radiation, including proton therapy, can be used in liver and pancreatic cancers previously considered unsuitable for it. His selected paper reports a multi-institutional phase 2 study of high-dose hypofractionated proton beam therapy in localised, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma. He leads proton and stereotactic radiotherapy studies in hepatobiliary and pancreatic cancers and neoadjuvant chemoradiation combinations, including losartan-based stromal modulation.
| Title | Journal | Year |
|---|---|---|
| Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma | Journal of Clinical Oncology | 2016 |
Shares Borderline resectable pancreatic ductal adenocarcinoma, Locally advanced unresectable pancreatic ductal adenocarcinoma, SBRT / SABR (stereotactic radiotherapy), Pancreatic ductal adenocarcinoma.
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, SBRT / SABR (stereotactic radiotherapy), Hepatocellular carcinoma, Pancreatic ductal adenocarcinoma.
Shares Borderline resectable pancreatic ductal adenocarcinoma, Locally advanced unresectable pancreatic ductal adenocarcinoma, SBRT / SABR (stereotactic radiotherapy).
Shares Borderline resectable pancreatic ductal adenocarcinoma, Locally advanced unresectable pancreatic ductal adenocarcinoma, SBRT / SABR (stereotactic radiotherapy).
Shares Massachusetts General Hospital Cancer Center, Proton therapy.
Shares Massachusetts General Hospital Cancer Center, Locally advanced unresectable pancreatic ductal adenocarcinoma, Pancreatic ductal adenocarcinoma.
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, SBRT / SABR (stereotactic radiotherapy).
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, SBRT / SABR (stereotactic radiotherapy).